secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kairos Pharma, LTD. (KAPA)
CIK:        0001962011
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001493152-25-002048
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kairos Pharma raises $3.5M in PIPE offering at $1.40/unit with warrants
-----------------------------------------------------------------------

- Raises $3.5M gross from sale of units at $1.40/Common Unit and $1.399/Pre-Funded Unit.
- Each Common Unit includes 1 share and 1.5 Common Warrants exercisable at $1.40 for 5.5 years.
- Insiders enter 90-day lock-up; registration rights for resale of shares and warrant shares.
- Closing expected January 15, 2025; D. Boral Capital and Boustead Securities as co-placement agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1962011/000149315225002048/0001493152-25-002048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1962011/000149315225002048/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer